See also this year's filing and all EDGAR filings for this company.
PDF Report 0001361248_2015_Tetralogic_Pharmaceuticals_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 10, '00201 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Calc 2)': 3}} |
Graph
Absolute values for 0001361248, Tetralogic Pharmaceuticals Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,857,363 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 58,477,982 |
| 2 | PropertyPlantAndEquipmentNet | 528,476 |
| 3 | remainder_Assets | 3,427,225 |
| 4 | LiabilitiesCurrent | 5,122,281 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 79,766,589 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,926,777 |
| 9 | ResearchAndDevelopmentExpense | 20,286,826 |
| 10 | remainder_Expenses | 5,931,389 |
| 11 | remainder_Revenues | 112,815 |
| 12 | remainder_NetIncome | 1,073,198 |
| 13 | remainder_ComprehensiveNetIncome | -77,148 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 118,291,046 |
| 1 | Liabilities | 84,888,870 |
| 2 | Expenses | 37,144,992 |
| 3 | Revenues | 112,815 |
| 4 | StockholdersEquity | 33,402,176 |
| 5 | NetIncome | -35,958,979 |
| 6 | ComprehensiveNetIncome | -35,997,553 |
| 7 | BaseVar | 120,794,034 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.362 |
| 9 | EconomicCapitalRatio | 1.76 |
Edgar->Model Mapping
Feature Distribution
